US 11938221
Multivalent nanoparticle-based vaccines
granted A61KA61K2039/575A61K2039/6031
Quick answer
US patent 11938221 (Multivalent nanoparticle-based vaccines) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/575, A61K2039/6031, A61K2039/6068, A61K2039/6075